Effects of N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of neutral- and acid alpha-glucosidases in human fibroblasts and HepG2 cells

Clin Chim Acta. 1989 Jun 15;182(1):41-52. doi: 10.1016/0009-8981(89)90148-4.


The effect of the glucose analogue N-hydroxyethyl-1-deoxynojirimycin (BAY m 1099) on the activity of alpha-glucosidases was studied in human fibroblasts and HepG2 cells. BAY m 1099 inhibits neutral and acid alpha-glucosidase activities of both cell types in a dosage-dependent and reversible manner. Inhibition of endoplasmic reticulum glucosidases I and/or II is suggested by delayed processing of lysosomal (acid) alpha-glucosidase. Competitive inhibition of mature acid alpha-glucosidase leads to lysosomal accumulation of glycogen as in glycogenosis type II. There seems to be little risk, however, of inducing this storage disorder when using the drug in a dose of 50 mg per os for treatment of type II diabetes. In high doses, the drug may prove useful for studying the pathogenesis of glycogenosis type II in vitro or in animal models.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives
  • Binding, Competitive
  • Carcinoma, Hepatocellular / enzymology*
  • Carcinoma, Hepatocellular / ultrastructure
  • Fibroblasts / enzymology*
  • Glucosamine / analogs & derivatives*
  • Glucosamine / pharmacology
  • Glycogen / metabolism
  • Glycoside Hydrolase Inhibitors*
  • Humans
  • Imino Pyranoses
  • Immunohistochemistry
  • Kinetics
  • Liver Neoplasms / enzymology*
  • Liver Neoplasms / ultrastructure
  • Lysosomes / enzymology
  • Microscopy, Electron
  • Molecular Weight
  • Tumor Cells, Cultured
  • alpha-Glucosidases / biosynthesis


  • Glycoside Hydrolase Inhibitors
  • Imino Pyranoses
  • miglitol
  • 1-Deoxynojirimycin
  • Glycogen
  • alpha-Glucosidases
  • Glucosamine